MX389304B - Producto farmaceutico. - Google Patents

Producto farmaceutico.

Info

Publication number
MX389304B
MX389304B MX2017003943A MX2017003943A MX389304B MX 389304 B MX389304 B MX 389304B MX 2017003943 A MX2017003943 A MX 2017003943A MX 2017003943 A MX2017003943 A MX 2017003943A MX 389304 B MX389304 B MX 389304B
Authority
MX
Mexico
Prior art keywords
aqueous composition
pharmaceutical product
solvate
inhibiting
salt
Prior art date
Application number
MX2017003943A
Other languages
English (en)
Other versions
MX2017003943A (es
Inventor
Shin Sugimoto
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55581239&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX389304(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kowa Co filed Critical Kowa Co
Publication of MX2017003943A publication Critical patent/MX2017003943A/es
Publication of MX389304B publication Critical patent/MX389304B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Wrappers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se provee una técnica para la supresión de la decoloración de una composición acuosa que contiene un derivado halogenado de isoquinolina durante la conservación a alta temperatura; una preparación farmacéutica obtenida al almacenar una composición acuosa que comprende un compuesto representado por la Fórmula (1), en donde X representa un átomo de halógeno, o una sal del mismo, o un solvato del compuesto o la sal del mismo, en un contenedor elaborado de resina a base de poliolefina. (ver Fórmula).
MX2017003943A 2014-09-25 2015-09-25 Producto farmaceutico. MX389304B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014194965 2014-09-25
PCT/JP2015/077014 WO2016047720A1 (ja) 2014-09-25 2015-09-25 医薬品

Publications (2)

Publication Number Publication Date
MX2017003943A MX2017003943A (es) 2017-06-30
MX389304B true MX389304B (es) 2025-03-20

Family

ID=55581239

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017003943A MX389304B (es) 2014-09-25 2015-09-25 Producto farmaceutico.

Country Status (13)

Country Link
US (1) US20170266080A1 (es)
EP (1) EP3199162B1 (es)
JP (6) JP6236167B2 (es)
KR (2) KR20180021929A (es)
CN (1) CN107073012A (es)
BR (1) BR112017006148A2 (es)
CA (1) CA2962624C (es)
ES (1) ES2909876T3 (es)
MX (1) MX389304B (es)
MY (1) MY179721A (es)
SG (1) SG11201702299SA (es)
TW (1) TWI686198B (es)
WO (1) WO2016047720A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI671071B (zh) * 2014-09-25 2019-09-11 日商興和股份有限公司 醫藥製劑
US11331390B2 (en) 2016-04-22 2022-05-17 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition
JP7153999B2 (ja) * 2016-04-22 2022-10-17 ロート製薬株式会社 水性組成物
JP7387835B2 (ja) * 2016-04-22 2023-11-28 ロート製薬株式会社 眼科組成物
CN109069421B (zh) * 2016-04-22 2021-10-12 乐敦制药株式会社 眼科组合物
JP2017197526A (ja) * 2016-04-22 2017-11-02 ロート製薬株式会社 眼科組成物
JP7159501B1 (ja) * 2016-04-22 2022-10-24 ロート製薬株式会社 眼科組成物
JP2017197524A (ja) * 2016-04-22 2017-11-02 ロート製薬株式会社 眼科組成物
JP7125250B2 (ja) * 2016-04-22 2022-08-24 ロート製薬株式会社 眼科組成物
JP2017226651A (ja) * 2016-06-15 2017-12-28 興和株式会社 水性なる組成物
JP7108596B2 (ja) * 2017-02-28 2022-07-28 興和株式会社 医薬
JP7108597B2 (ja) * 2017-02-28 2022-07-28 興和株式会社 医薬品
KR20190119055A (ko) * 2017-02-28 2019-10-21 코와 가부시키가이샤 의약 제제
CN110494138B (zh) * 2017-03-27 2023-07-11 兴和株式会社 医药制剂
WO2019167183A1 (ja) * 2018-02-28 2019-09-06 興和株式会社 医薬品製剤
JP2020193174A (ja) * 2019-05-29 2020-12-03 興和株式会社 水性組成物
JP7595233B1 (ja) * 2024-07-22 2024-12-05 興和株式会社 医薬
JP7663792B1 (ja) * 2024-07-22 2025-04-16 興和株式会社 医薬
JP7783945B1 (ja) * 2024-07-22 2025-12-10 興和株式会社 医薬
JP7635471B1 (ja) * 2024-09-12 2025-02-25 興和株式会社 医薬製剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1726306B1 (en) * 2004-03-16 2013-10-30 Asahi Kasei Pharma Corporation Fasudil-containing preparation and method of improving stability thereof
TWI367098B (en) * 2004-12-23 2012-07-01 Kowa Co Treating agent for glaucoma
JP2006290827A (ja) * 2005-04-13 2006-10-26 Kowa Co 緑内障予防又は治療剤
JP4800720B2 (ja) * 2005-09-21 2011-10-26 興和株式会社 点眼用組成物
US20080064681A1 (en) * 2006-09-11 2008-03-13 Hiroyoshi Hidaka Therapeutic agent for treating glaucoma
KR20110022686A (ko) * 2008-07-25 2011-03-07 아사히 가세이 파마 가부시키가이샤 술폰아미드 화합물을 함유하는 안정적인 수용액 조성물
WO2015156321A1 (ja) * 2014-04-09 2015-10-15 ロート製薬株式会社 眼科組成物
TWI671071B (zh) * 2014-09-25 2019-09-11 日商興和股份有限公司 醫藥製劑
CA2970254A1 (en) * 2014-12-12 2016-06-16 Kowa Company, Ltd. Composition

Also Published As

Publication number Publication date
SG11201702299SA (en) 2017-04-27
EP3199162A4 (en) 2018-04-25
WO2016047720A1 (ja) 2016-03-31
CA2962624A1 (en) 2016-03-31
TWI686198B (zh) 2020-03-01
BR112017006148A2 (pt) 2017-12-26
KR20180021929A (ko) 2018-03-05
EP3199162B1 (en) 2022-03-09
CN107073012A (zh) 2017-08-18
JPWO2016047720A1 (ja) 2017-06-29
CA2962624C (en) 2022-08-30
KR101860279B1 (ko) 2018-05-21
JP2023041805A (ja) 2023-03-24
JP2019199483A (ja) 2019-11-21
EP3199162A1 (en) 2017-08-02
MX2017003943A (es) 2017-06-30
US20170266080A1 (en) 2017-09-21
KR20170063572A (ko) 2017-06-08
JP6236167B2 (ja) 2017-11-22
JP2021107462A (ja) 2021-07-29
MY179721A (en) 2020-11-11
JP2018021077A (ja) 2018-02-08
ES2909876T3 (es) 2022-05-10
TW201613602A (en) 2016-04-16
JP2024160370A (ja) 2024-11-13

Similar Documents

Publication Publication Date Title
MX389304B (es) Producto farmaceutico.
WO2016011390A8 (en) Irak4 inhibiting agents
TN2017000524A1 (en) New bicyclic derivatives, a process for their preparation and pharmaceutical compositions containing them
TN2018000395A1 (en) New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
MY196243A (en) Dihydropyrimidine Compounds and Their Application In Pharmaceuticals
WO2016105564A8 (en) Quinazoline derivatives used to treat hiv
EA201791692A1 (ru) 4H-ПИРРОЛО[3,2-c]ПИРИДИН-4-ОНОВЫЕ ПРОИЗВОДНЫЕ
MY178371A (en) Pharmaceutical preparation
NZ729037A (en) Carboxylic acid compound, method for preparation thereof, and use thereof
TN2018000119A1 (en) Dihydroimidazopyrazinone derivatives useful in the treatment of cancer
MY194116A (en) Pharmaceutical compounds
MX377202B (es) Derivado basado en 1,2-naftoquinona y metodo de preparacion del mismo.
MX376283B (es) Compuestos de imidazopiridazina.
MX373700B (es) Composicion acuosa novedosa.
MX2017007574A (es) Composicion.
PH12018501709A1 (en) Naphthridinedione derivatives
IL260040A (en) Complexes of celecoxib and its salts and derivatives, a process for their preparation and pharmaceutical preparations containing them
MX2017007572A (es) Composicion acuosa.
AU2015280874A1 (en) Novel heterocyclic compound
WO2015191681A3 (en) Substituted pyridinones as mgat2 inhibitors
WO2017214423A8 (en) Derivatives of thailanstatin a, methods of treatment and methods of synthesis thereof
WO2016057660A8 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
WO2015102024A3 (en) Novel substituted 5 membered heterocyclic compounds and preparation thereof
WO2017046816A3 (en) Process for the preparation of derivatives of benzodioxole
HK40113576A (zh) 用於制备1，3-苯并二氧杂环戊烯杂环化合物的方法